SG Americas Securities’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-43,400
Closed -$9K 2887
2024
Q1
$9K Hold
43,400
﹤0.01% 2894
2023
Q4
$23K Hold
43,400
﹤0.01% 2994
2023
Q3
$56K Buy
+43,400
New +$2.28M ﹤0.01% 2911
2021
Q1
Sell
-130,000
Closed -$532K 3299
2020
Q4
$532K Buy
130,000
+50,000
+63% +$1.8M ﹤0.01% 1944
2020
Q3
$203K Buy
+80,000
New +$3.08M ﹤0.01% 2146
2020
Q2
Sell
-20,000
Closed -$86K 3697
2020
Q1
$86K Buy
+20,000
New +$781K ﹤0.01% 3055
2019
Q1
Sell
-75,000
Closed -$4K 3370
2018
Q4
$4K Hold
75,000
﹤0.01% 2979
2018
Q3
$4K Hold
75,000
﹤0.01% 3080
2018
Q2
$25K Hold
75,000
﹤0.01% 3230
2018
Q1
$121K Hold
75,000
﹤0.01% 2799
2017
Q4
$182K Buy
+75,000
New +$2.07M ﹤0.01% 2510

Other funds holding BSX

SG Americas Securities's BSX Position: Q1 2026 in Review

SG Americas Securities increased its Boston Scientific (BSX) stake by 141% in Q1 2026, buying an estimated $43.6M and bringing the position to 931,155 shares worth $58.4M. The position accounts for 0.06% of the portfolio, ranked #249.

SG Americas Securities first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • SG Americas Securities held 931,155 shares of Boston Scientific worth $58.4M as of Q1 2026.
  • SG Americas Securities bought 544,637 Boston Scientific shares in Q1 2026, an estimated $43.6M.
  • Boston Scientific made up 0.06% of SG Americas Securities's portfolio in Q1 2026, its #249 holding.
  • SG Americas Securities first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
  • 1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.